Cargando…
Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
Aim: This study aimed to reveal whether a larger postprocedural minimum lumen area (MLA) would reduce restenosis risk after endovascular therapy (EVT) using drug-coated balloons (DCBs) in femoropopliteal (FP) lesions. Methods: This retrospective, nonrandomized, single-arm, and multicenter registry a...
Autores principales: | Horie, Kazunori, Takahara, Mitsuyoshi, Nakama, Tatsuya, Tanaka, Akiko, Tobita, Kazuki, Hayakawa, Naoki, Mori, Shinsuke, Iwata, Yo, Suzuki, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499445/ https://www.ncbi.nlm.nih.gov/pubmed/36436877 http://dx.doi.org/10.5551/jat.63886 |
Ejemplares similares
-
Retrospective multicenter registry for endovascular treatment with newer devices in over 25‐cm femoropopliteal artery disease: A retrospective observational study
por: Horie, Kazunori, et al.
Publicado: (2022) -
Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
por: Hayakawa, Naoki, et al.
Publicado: (2022) -
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021) -
Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022) -
Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
por: Tobita, Kazuki, et al.
Publicado: (2023)